Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picosecond Laser + Hydroquinone for Melasma
NCT03049059Phase 2Completed
- Sponsor
- Mae Fah Luang University Hospital
- Start
- Jun 2016
- Primary completion
- Dec 2016
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Mae Fah Luang University Hospital. Primary endpoints: Modified Melasma Area and Severity Index at 12 weeks and Proportion of subjects with at least 50% MASI score improvement at 12 weeks. Started Jun 2016; status: completed.
Beyond the preview
Go deeper on NCT03049059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03049059.